About
Josh Disbrow, a distinguished figure shaping the pharmaceutical sector, is nestled in Denver, CO. With over 25 years of industry expertise, he’s carved a niche spanning pharmaceuticals, diagnostics, and medical devices. His journey is a narrative of visionary leadership, starting with the founding of Aytu BioPharma, where he orchestrated unprecedented growth, alongside his commendable contributions to other prominent pharmaceutical ventures. Beyond the professional sphere, Josh’s life unfolds as a tapestry of cherished family ties, musical pursuits, and a commitment to philanthropy.
Architect of Success: Aytu BioPharma’s Ascendancy
At present, Josh wears multiple hats, most notably serving as the Chief Executive Officer and Board Director of Aytu BioPharma, a company he co-founded in 2015. His guidance saw Aytu BioPharma’s triumphant listing on NASDAQ in 2017, and in just seven years, the company soared past the $100 million annual revenue milestone. Not confined to financial prowess, Josh’s strategic prowess shines through the execution of four successful company acquisitions in under four years, underscoring his finesse in navigating intricate business terrains.
Guardian of Governance: Zynex, Inc.
Josh’s influence extends beyond Aytu BioPharma. As a Director at Zynex, Inc., a publicly-listed medical device firm, he shoulders a leadership role on the board. Notably, he leads the Nominating and Governance Committee, exemplifying his commitment to robust corporate governance practices.
Chapters of Triumph: A Career Unveiled
Josh’s career trajectory is a testament to consistent progression. Launching as a sales representative at Glaxo Wellcome (now GlaxoSmithKline plc), he ascended the ranks, assuming pivotal commercial and leadership roles at distinguished entities like Cyberonics, LipoScience, Arbor Pharmaceuticals, and Ampio Pharmaceuticals. At Arbor, his imprint was transformational, steering the company from pre-commercialization to a remarkable revenue of over $250 million in less than five years.
Educational Stepping Stones: Anchoring Knowledge
Josh Disbrow’s professional understanding rests on a solid academic foundation. He graduated with honors from North Carolina State University, securing a Bachelor of Science in Management. Further honing his skills, he earned a Master of Business Administration from Wake Forest University School of Business.
Generosity Amplified: Philanthropy’s Embrace
Beneath the veneer of professional achievement lies Josh’s unwavering commitment to philanthropy. In partnership with his wife, he champions Invest-in-Kids, a Colorado-based organization, actively participating in the annual Jane-A-Thon fundraiser that benefits families and children in Colorado. This spirit of giving extends through regular contributions to local charities and a church. A poignant testament to his ethos is his recent mission trip to Puerto Penasco, Mexico, where he rolled up his sleeves to construct a home for a needy family. Josh’s influence is also felt within Aytu BioPharma, where his leadership enables employees to embark on Volunteer Days, aligning with their chosen causes.
Symphony of Interests: Personal Passions
Josh’s kaleidoscope of interests extends into his personal life. His musical journey commenced in the 7th grade with guitar playing, a passion that still resonates. He finds solace in genres spanning rock, jam, Americana, and bluegrass, ardently following bands like Phish, Goose, Widespread Panic, and Greensky Bluegrass.
Venturing into the great outdoors, Josh relishes hiking and the scenic grandeur of Colorado. Skiing, biking, and attending sports and music events further fuel his zest for life. A dedicated sports enthusiast, his allegiance lies with the Denver Broncos and the North Carolina State University Wolfpack.
Horizons Awaiting: Glimpses of Tomorrow
The horizon is ablaze with significant events for Josh Disbrow. Aytu BioPharma is poised to celebrate its ninth anniversary in April 2024. Marking a personal milestone, he and his college sweetheart will commemorate their 25th wedding anniversary in July 2024—anticipation mounts for Aytu BioPharma’s fiscal 2023 annual report, set to be unveiled by September 2023.
In Summation: A Life of Inspiration
Disbrow’s life narrative is a symphony of professional excellence, familial bonds, and myriad passions. As a dynamic executive, he’s steered businesses toward unparalleled success. Simultaneously, his dedication to music, family, and philanthropy paints the portrait of a well-rounded individual whose influence resonates within both boardrooms and communities. Josh is a beacon of inspiration through his journey, illuminating corporate pathways and the human spirit.
Josh Disbrow 